NutriBand (NTRB) Revenue Growth (3y) (2021 - 2026)
NutriBand (NTRB) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 77.85% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -25.02% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 42.02% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 59.40% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -37.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 76.62% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.80% |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | -3.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -3.14% |
| Jan 31, 2026 | -8.76% |
| Oct 31, 2025 | -17.58% |
| Jul 31, 2025 | 10.92% |
| Apr 30, 2025 | 11.78% |
| Jan 31, 2025 | 9.31% |
| Oct 31, 2024 | 31.65% |
| Jul 31, 2024 | 27.48% |
| Apr 30, 2024 | -1.96% |
| Jan 31, 2024 | 54.62% |
| Oct 31, 2023 | 2.98% |
| Jul 31, 2023 | 98.04% |
| Apr 30, 2023 | 58.68% |
| Jan 31, 2023 | 191.82% |
| Oct 31, 2022 | 95.61% |
| Jul 31, 2022 | 82.61% |
| Apr 30, 2022 | 35.15% |
| Oct 31, 2021 | 79.42% |